19h
New study finds skin conditions remain prevalent in people with HIV despite advances in treatment
A new study led by researchers at the George Washington University and published through the DC Cohort, one of the largest HIV longitudinal studies in the United States, finds that nearly half of ...
Those who had at least 1 inpatient insurance claim for HIV-related treatment or unrelated treatment with an HIV diagnosis were considered to be living with HIV. Receiving 1 or more opioid ...
South Africa's health minister has called lenacapavir, the first twice-yearly HIV prevention jab, a "groundbreaking" tool ...
More than 60 abstracts will be presented from the ViiV portfolio, including updates from the phase 1 crossover study, the first comparing the acceptability and tolerability of long acting cabotegravir ...
GlaxoSmithKline Plc said an injection of its cabotegravir drug given every two months, in combination with Johnson & Johnson's rilpivirine, was recommended for approval to treat HIV infections by a ...
Human immunodeficiency viruses (HIV) are insidious. They can evade the immune defense and antiviral drugs by becoming "latent ...
The Memphis area now ranks first in the nation for new HIV infections, according to local health officials. But a global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback